Intelligent Enzymes Designed for Your Biology إِنْزِيمَاتٌ ذَكِيَّةٌ صُمِّمَتْ لِحَيَاتِكَ
Zymetron Biotech creates precision biological solutions engineered to solve what nature leaves unfinished.
Enzymes that adapt to your biology
Zymetron Biotech develops intelligent enzymes engineered to solve complex biological challenges. We combine precision design with adaptive functionality, creating solutions that work with living systems rather than against them.
Progress that signals market readiness
Zymetron Biotech has established foundational capabilities and strategic positioning within the enzyme biotechnology sector. These milestones reflect our trajectory toward commercial viability.
11
Operating countries
Initial target markets across MEA region
5
Enzyme SKUs in development
Distinct intelligent enzyme systems in active development for targeted biological applications.
1
Strategic customer centeric platform
Unique market access to customers in MEA region.
1
Operating Region
KSA-headquartered platform with MEA-wide commercial reach
Ready to explore what intelligent enzymes can do for your biology?
Connect with our team to discuss partnership opportunities, investment, or technical collaboration. We're building the future of biological innovation.
Common questions about Zymetron
Find answers about our intelligent enzymes and how we're advancing biological applications.
What makes Zymetron's enzymes intelligent?
Our intelligent enzymes are designed with adaptive properties that respond to biological environments, enabling more precise control and efficiency in applications. This approach sets us apart from traditional enzyme solutions by delivering both specificity and performance.
What biological applications are you targeting?
Our initial focus is digestive enzyme health in the MENA region, where cultural diet patterns and a 68–70% lactose intolerance prevalence create a large, underserved market. Phase 1 covers three Halal-certified SKUs targeting Saudi Arabia and the UAE. Phase 2 expands to systemic enzyme applications and five additional GCC markets.
When will Zymetron's products be available?
We finalized the pre-launch concept stage, focused on establishing our technology foundation and investor partnerships. The pre-launch regulatory and supply chain preparation phase started and targeting commercial launch Q2 2027
How is Zymetron funded?
We're actively seeking strategic investors and partners who recognize the potential of intelligent enzyme technology. Our business model is designed to attract both venture and strategic capital aligned with our long-term vision.
Who leads the Zymetron team?
Zymetron was founded by Dr. Mohamed Issa, a pharmaceutical executive with more than 24 years of experience in the pharmaceutical industry, bringing deep expertise in biotechnology and enzyme development. We are building a team of specialists dedicated to advancing the field of intelligent biological systems.
How can I learn more or explore partnership opportunities?
We invite potential investors and partners to reach out directly. Get in touch through our contact channels to discuss how Zymetron's technology aligns with your strategic interests.
Ready to explore more?
Contact us to discuss investment opportunities or learn more about our technology and vision.